Molecular Diagnosis of Systemic Autoinflammatory Diseases | MicrobiomeTrials← Back to trialsNCT05364294
Molecular Diagnosis of Systemic Autoinflammatory Diseases
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-05-18Est. Completion: 2032-05-31
Enrollment target: 300 participants Locations- Trousseau Hospital, Paris, France
Other microbiome trials you might be interested in
Sickle Cell Disease
Background:
Sickle Cell Disease (SCD) is a blood disorder that occurs mainly in people of African descent. Researchers …
Bethesda, United StatesCompleted Dec 9, 2019
Uveitis
Background:
\- Uveitis is a general term describing a group of inflammatory diseases of the eye. The causes of uveitis …
Bethesda, United StatesCompleted Jun 29, 2022
Inflammatory Bowel Diseases (IBD)Crohn Disease
Colitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032